# Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor

> **NCT01612390** · — · UNKNOWN · sponsor: **Rasha Mohammed Mohammed Badawi** · enrollment: 180 (estimated)

## Conditions studied

- Postpartum Hemorrhage Prevention by Using Oxytocin Verses Misoprostol

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01612390
- **Lead sponsor:** Rasha Mohammed Mohammed Badawi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2012-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612390, "Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01612390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*